PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences:
Live webcasts will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Ariane Lovell
Finn Partners
ariane.lovell@finnpartners.com
Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions CAMPBELL, Calif.,…
SMITHSBURG, Md., Jan. 9, 2025 /PRNewswire/ -- UNC Health Wayne, a leading healthcare institution committed…
ALTA LOMA, Calif., Jan. 9, 2025 /PRNewswire/ -- GTSCX.AI – What does transforming a contact…
Driven by a network of more than 4,200 sites of care now using the AssistPoint®…
ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ -- CellFE®, a leader in non-viral gene editing technology,…
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Recent technological advancements in sensing, big data, cloud…